Literature DB >> 29605478

Practice patterns of image guided particle therapy in Europe: A 2016 survey of the European Particle Therapy Network (EPTN).

Alessandra Bolsi1, Marta Peroni1, Dante Amelio2, Alexandru Dasu3, Markus Stock4, Iuliana Toma-Dasu5, Petra Witt Nyström6, Aswin Hoffmann7.   

Abstract

BACKGROUND AND
PURPOSE: Image guidance is critical in achieving accurate and precise radiation delivery in particle therapy, even more than in photon therapy. However, equipment, quality assurance procedures and clinical workflows for image-guided particle therapy (IGPT) may vary substantially between centres due to a lack of standardization. A survey was conducted to evaluate the current practice of IGPT in European particle therapy centres.
MATERIAL AND METHODS: In 2016, a questionnaire was distributed among 19 particle therapy centres in 12 European countries. The questionnaire consisted of 30 open and 37 closed questions related to image guidance in the general clinical workflow, for moving targets, current research activities and future perspectives of IGPT.
RESULTS: All centres completed the questionnaire. The IGPT methods used by the 10 treating centres varied substantially. The 9 non-treating centres were in the process to introduce IGPT. Most centres have developed their own IGPT strategies, being tightly connected to their specific technical implementation and dose delivery methods.
CONCLUSIONS: Insight into the current clinical practice of IGPT in European particle therapy centres was obtained. A variety in IGPT practices and procedures was confirmed, which underlines the need for harmonisation of practice parameters and consensus guidelines.
Copyright © 2018 Elsevier B.V. All rights reserved.

Keywords:  Image guidance; Particle therapy; Survey

Mesh:

Year:  2018        PMID: 29605478     DOI: 10.1016/j.radonc.2018.03.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Streamlining the image-guided radiotherapy process for proton beam therapy.

Authors:  Lucy Siew Chen Davies; Louise McHugh; Marianne Aznar; Josh Lindsay; Cynthia Eccles
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

2.  Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Authors:  Giulia Riva; Sara Imparato; Giovanni Savietto; Mattia Pecorilla; Alberto Iannalfi; Amelia Barcellini; Sara Ronchi; Maria Rosaria Fiore; Chiara Paganelli; Giulia Buizza; Mario Ciocca; Guido Baroni; Lorenzo Preda; Ester Orlandi
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

3.  Long-time clinical experience in patient setup for several particle therapy clinical indications: management of patient positioning and evaluation of setup reproducibility and stability.

Authors:  Rosalinda Ricotti; Andrea Pella; Barbara Tagaste; Giovanni Elisei; Giulia Fontana; Maria Bonora; Mario Ciocca; Francesca Valvo; Roberto Orecchia; Guido Baroni
Journal:  Br J Radiol       Date:  2019-11-14       Impact factor: 3.629

4.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

5.  NRG Oncology Survey of Monte Carlo Dose Calculation Use in US Proton Therapy Centers.

Authors:  Liyong Lin; Paige A Taylor; Jiajian Shen; Jatinder Saini; Minglei Kang; Charles B Simone; Jeffrey D Bradley; Zuofeng Li; Ying Xiao
Journal:  Int J Part Ther       Date:  2021-05-25

Review 6.  Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.

Authors:  Julia M Pakela; Antje Knopf; Lei Dong; Antoni Rucinski; Wei Zou
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 7.  Particle therapy in Europe.

Authors:  Cai Grau; Marco Durante; Dietmar Georg; Johannes A Langendijk; Damien C Weber
Journal:  Mol Oncol       Date:  2020-04-22       Impact factor: 7.449

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.